Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea's Trade Commission Offers Payment To Whistleblowers Reporting Rebates

This article was originally published in PharmAsia News

Executive Summary

SEOUL - In its latest anti-rebate move, South Korea's Fair Trade Commission is offering up to KRW100 million ($82,440) to whistleblowers who uncover illegal rebates offered by pharma companies for sales of their products to hospitals. The new punitive system took effect June 17
Advertisement

Related Content

Korea Trade Commission Launches Kickback Probes Of Pharmaceutical Firms Following Similar Action By Drug Regulators
Korea Trade Commission Launches Kickback Probes Of Pharmaceutical Firms Following Similar Action By Drug Regulators
Hospital Bribery Continues In Asia Despite Increased Enforcement
Korea's National Tax Service Adds Momentum To Government Drive Against Rebates; 18 Pharmas Taxed, MNCs Also?
Both MNCs, Local Korean Pharmas Under Korean Government Surveillance For IP Protection
OECD Recommends Changes in Korea's Healthcare System In Its First Survey Of Korea's Pharma Sector
Korea's Anti-Rebate Laws Seen Sparking More Demand For MNC Products
Four Major South Korean Hospitals Are Penalized For Soliciting "Donations" From Pharmaceutical Outfits Including MNCs
Four Major South Korean Hospitals Are Penalized For Soliciting "Donations" From Pharmaceutical Outfits Including MNCs
Korean Health Minister Could Enlist Special Prosecutor To Fight Kickbacks By Drug Makers
Advertisement
UsernamePublicRestriction

Register

SC075206

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel